The "Three-year Action Plan for the Construction of a Strong Manufacturing City in Tianjin (2021-2023)" proposes to adhere to the intelligent technology industry as the guide, focus on strengthening strategic emerging industries such as biomedicine, new energy, and new materials, consolidate and enhance the advantages of equipment manufacturing, automobiles, petrochemicals, aerospace and other advantageous industries, and accelerate the construction of a "1+3+4" modern industrial industry system. The biomedical industry is one of the three strategic emerging industries in Tianjin, and also the "one wing" in the "one main and two wings" industrial innovation pattern in the manufacturing strong city plan, with the whole biomedical industry chain including chemical drugs, traditional Chinese medicine, biopharmaceuticals, and medical devices, and has completed the layout in the main links of the value chain such as innovation incubation, industrialization and circulation. In 2020, the output value of the biomedical industry will be 62.7 billion yuan, as a strong chain of ten key industrial chains, it is necessary to give full play to the advantages of enterprises, parks, platforms, talents and projects to enhance the development level and overall competitiveness of the industrial chain.
Cultivate leading enterprises and improve leading efficiency
Enhance the development level and radiation range of industry giants, promote the product research and development and listing of specialized new "small giants" enterprises, and build a double giant development echelon with large backbone enterprises and innovative small and micro enterprises as the main body. Tianjin has a number of industry leaders such as Tianjin Pharmaceutical Group and Tasly, and has cultivated a number of innovative biotechnology enterprises such as Hankang Pharmaceutical, Sainuo Medical, and Tianyan Medical Education. A group of young enterprises represented by Heyuan Biotechnology (Tianjin) Co., Ltd. have become the rising stars of the cell industry, and cell therapy products with independent intellectual property rights have ranked among the first echelons in this field. In accordance with the country's strategic layout of the biomedical industry and the city's industrial planning, with the core advantages of enterprises as the breakthrough point and leading enterprises as the focus, we will form core advantages and play a leading role in the aspects of strong chain replenishment, enterprise introduction, talent pooling, innovation collaboration, etc., significantly enhance core technologies, market share and service capabilities, and promote the formation of highly active industrial clusters.
Create key parks and highlight the agglomeration effect
In accordance with the principle of "one park, one feature, one district and one brand", we will create a high-quality and high-energy theme park with a cluster of parks and chain clusters. Tianjin's biomedical industry has basically formed a development pattern with Binhai New Area as the core and Wuqing, Beichen, Xiqing and Jinnan with their own characteristics. Each district focuses on the six directions of synthetic biology, medical devices, chemical pharmaceuticals, smart medical treatment, modernization of traditional Chinese medicine, and pharmaceutical R&D service outsourcing around the industrial base, and highlights the construction of key parks and characteristic biomedical industries. Taking Binhai New Area as an example, we will actively promote the construction of "one laboratory, two bases and three centers", take the cell industry as the breakthrough point, deeply cultivate the fields of drug innovation, cell products and pharmaceutical services, and achieve obvious first-mover advantages and agglomeration effects. At the same time, all districts should rely on key parks to form a coordinated linkage development mechanism between Beijing, Tianjin and Hebei, strengthen consultation and communication on industrial development planning, improve the carrying capacity of absorbing Beijing's spillover resources, communicate with and complement each other with the pharmaceutical industry in Hebei Province, advocate division of labor and cooperation, and improve the level of regional industrial chain integration.
Build an innovation platform and adhere to the leadership of science and technology
With scientific research institutions, enterprises, and universities as the main body, collaborative innovation as the main line, effectively integrate the innovation elements such as government, industry, learning, research, gold, use, and services, and build an original innovation source system. Tianjin biomedical field has more than 100 scientific research and innovation platforms with international standards, such as the State Key Laboratory and the National Industrial Technology Innovation Strategic Alliance, a number of backbone enterprises and modern Chinese medicine innovation centers, two professional undergraduate colleges of Tianjin Medical University and Tianjin University of Traditional Chinese Medicine, and the development and industrial agglomeration of key parks rely on the introduction of innovation platforms and enterprise technology centers to promote the initial formation of a relatively complete innovation and research and development system. Effectively use the advantages of innovation platform resources, strengthen the main body and excellent environment, continuously improve the comprehensive ability of scientific and technological innovation, create a tianjin characteristic brand, enhance industrial recognition, promote the inheritance and innovation of the traditional Chinese medicine industry, promote the rapid development of high-end biological products such as cell therapy, gene therapy, new vaccines, antibody drugs, etc., and effectively drive the industrial value chain to the high-end.
Increase the introduction of talents and explore scientific and educational resources
Closely follow the industrial chain, build a talent chain, take the needs of enterprises and industrial development as the guide, strategically introduce talents, forward-looking training talents, enlarge the talent reservoir, and activate the main engine of development. Increase the introduction of high-level talent funding, sort out the talent gap, and implement the "one enterprise, one policy" system into the talent support policy. Establish a biomedical industry talent demand account, find out the bottom number, accurately match the demand, provide a good scientific research environment and attractive salary treatment, and provide a strong guarantee in terms of relocation, housing and medical treatment, and children's schooling. Tianjin has a number of high-level universities and top three hospitals, with many scientific research institutes and many scientific researchers. As the basic link of educating people, colleges and universities will accelerate the implementation of the "introduction of enterprises into schools" initiative, break down talent barriers, enhance the adaptability of talent training and industrial needs, and create a development community. The government, enterprises and universities work together to gather leading talents, support talents and young talents to form a pyramid-shaped talent echelon and consolidate the talent foundation for a high-quality and high-energy innovation platform.
Strengthen project support and accurately attract investment
Do a good job in planning the biomedical industry chain, coordinate the short-term and long-term goals of industrial development, optimize the development ecology of the industrial chain, innovate the attraction mechanism, and enhance the vitality of industrial capital. At present, Tianjin is accelerating the implementation of a number of major projects and industrial innovation platforms such as the Beijing-Tianjin-Hebei Tianjin Traditional Chinese Medicine Industry Base, the Cell Engineering Innovation Center, and the Innovation Center for Key Technologies and Equipment of Traditional Chinese Medicine Intelligence. It is necessary to strengthen accurate investment promotion, promote the construction of digital platforms, use big data, artificial intelligence and other technologies to build a project resource database connecting the whole country and even the world, efficiently serve the development needs of Tianjin's biomedical industry, track the development dynamics of the biomedical industry in real time, intelligently predict the development potential of related fields, and accurately promote and match investment projects. In the face of the shortcomings of Tianjin's overall financing quota and insufficient vitality of the capital market, give play to the fulcrum role of government guidance funds such as the Haihe Industrial Fund, rely on advantageous innovation projects, build an effective docking platform, transmit financing demand information, actively introduce social capital, and promote the in-depth coordinated development of industrial capital, financial institutions and enterprises.
The advanced industrial base and the modernization of the industrial chain are the key links in the implementation of the action plan for a strong manufacturing city, and are the strategic starting point for accelerating the construction of a national advanced manufacturing research and development base, giving full play to the advantages of the strong chain of the biomedical industry, enhancing the ability to control independently, continuously enhancing the initiative of development, forging long boards, and helping the Tianjin industrial chain achieve high-quality development.